Motley Fool Wealth Management’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Other funds holding MRNA
TP
Motley Fool Wealth Management's MRNA Position: Q1 2025 in Review
Motley Fool Wealth Management sold out of Moderna (MRNA) in Q1 2025, closing a stake of 155,388 shares — an estimated $6.19M sold.
Motley Fool Wealth Management first reported a position in MRNA in Q1 2024 and held it in 4 quarters. The position peaked at $23.2M in Q2 2024. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.
- Motley Fool Wealth Management reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
- Motley Fool Wealth Management sold 155,388 Moderna shares in Q1 2025, an estimated $6.19M.
- Motley Fool Wealth Management first reported a position in Moderna in Q1 2024 and held it in 4 quarters.
- Motley Fool Wealth Management's Moderna position peaked at $23.2M in Q2 2024.
- 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.
Based on Motley Fool Wealth Management's 13F filing for Q1 2025, filed 12 May 2025.